USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI

Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 ' 13 November 2024, as Voluntary Action Indicated (VAI).